Data-driven strategies for discovery and development of new CNS drugs

Data-driven modeling serves as a powerful approach in drug discovery, leveraging large datasets to identify potential chemical entities for treating diseases. By integrating experimental and computational data, Professor Aleksander Mendyk explores data-driven strategies to analyze complex relationships within broad datasets. His work surpasses classical experimental models in efficiency and predictive power, enhancing drug discovery and development.

This video is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. You are free to share it for non-commercial purposes with proper attribution, but no modifications or adaptations are allowed.

1.   Why use this method?

The method focuses on data-driven modeling as a fundamental approach in drug discovery. Its main rationale is to advantage large datasets to analyze potential chemical entities capable of curing diseases. Data-driven methodologies are essential for examining complicated relationships within broad and diverse datasets, which often surpass classical experimental models efficiency and effectiveness in predicting drug candidates.

2.  What you’ll need

Materials and Equipment:

Computer Hardware:

• High-performance computing systems with sufficient computational power (preferably equipped with GPUs)

Software:

• Data analysis programs (e.g., Python, R, or dedicated drug discovery tools)
• Machine learning frameworks and libraries (e.g., TensorFlow, PyTorch)

Laboratory Equipment:

• Automated high-throughput screening systems (for experimental validation of computational results)
• Common laboratory equipment for chemical synthesis and analysis (e.g., spectrophotometers, chromatographs)

Data Sources:

• Access to proprietary and public chemical databases.
• Datasets containing genomic and chemical properties for training models.

3. Step-by-step instructions

1. Data Collection:

• Collect data on known chemical and their biological effectiveness, including IC50 data and physical-chemical properties
• Verify that the data is high quality and accurately represents the target conditions

2. Data Preprocessing:

• Clear and preprocess the data to eliminate noise and unnecessary features
• Standardize and encode chemical structures into numerical formats suitable for computational modeling

3. Model Development:

• Choose the applicable model type (e.g., artificial neural networks)
• Separate the datasets into training and test sets to assess the effectiveness of the model
• Train the model using the training datasets, tuning parameters as needed according to performance metrics

 4. Model Validation:

• Use the datasets to validate the model. Cross-validation techniques can help assure the robustness of the model
• Evaluate model performance by measuring its accuracy in predicting known outcomes and its ability to generalize to new data

5. Application in Drug Discovery:

• Apply the developed model to predict new chemical structures and their potential efficacy
• Integrate findings with wet lab experiments to confirm the accuracy of computational predictions

4. Practical tips

• Collaboration with experts in pharmacology and medicinal chemistry is essential to ensure the relevance of modeled properties to drug efficacy
• Ongoing refinement of models using updated data and emerging research is crucial for maintaining accuracy
• Be prepared to address limitations in data quality and quantity, as they can substantially influence the modeling results

5.  Critical appraisal & implications for future research

While data-driven modeling holds potential in advancing drug discovery, challenges related to data scarcity and the complexity of biological systems remain. Future research should prioritize:

• Developing integrated data platforms that combine different omics data to enrich datasets for training models
• Investigating the impact of genetic and ethnic diversity on drug predictions to ensure models accurately represent global populations
• Creating methodologies that promote increased automation while minimizing the reliance on large historical datasets

This protocol is licensed under a Creative Commons Attribution-NonCommercial (CC BY-NC) license, allowing sharing and adaptation for non-commercial purposes with proper attribution.